Wells Fargo & Company Forecasts Strong Price Appreciation for Agilon Health (NYSE:AGL) Stock

Agilon Health (NYSE:AGL – Get Free Report) had its price target hoisted by research analysts at Wells Fargo & Company from $146.00 to $170.00 in a report issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 46.95% from the stock’s previous close.

A number of other equities analysts have also weighed in on the company. Royal Bank Of Canada set a $125.00 target price on Agilon Health in a research report on Tuesday, September 15th. Sanford C. Bernstein raised shares of Agilon Health from a “market perform” rating to an “outperform” rating and raised their price target for the company from $86.00 to $125.00 in a report on Tuesday, September 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the stock a “hold” rating in a research note on Thursday, August 6th. Finally, Citigroup raised shares of Agilon Health from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $105.00 to $115.00 in a report on Monday, August 10th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $107.38.

Check Out Our Latest Research Report on AGL

Agilon Health Stock Up 4.9%

Shares of Agilon Health stock traded up $5.39 on Friday, reaching $115.69. The company’s stock had a trading volume of 152,510 shares, compared to its average volume of 219,597. Agilon Health has a 52 week low of $7.48 and a 52 week high of $133.04. The firm’s fifty day simple moving average is $90.70 and its two-hundred day simple moving average is $68.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.94 billion, a price-to-earnings ratio of -20.84 and a beta of 3.10.

Agilon Health (NYSE:AGL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $1.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.23) by $3.20. Agilon Health had a negative return on equity of 51.97% and a negative net margin of 1.45%. The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.46 billion. Equities analysts anticipate that Agilon Health will post -2.90 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Tidal Investments LLC purchased a new position in Agilon Health in the second quarter worth about $1,405,000. Rubicon Founders LLC purchased a new stake in shares of Agilon Health during the 2nd quarter valued at about $11,290,448. State Street Corp purchased a new stake in shares of Agilon Health during the 2nd quarter valued at about $30,024,000. Ellsworth Advisors LLC bought a new position in shares of Agilon Health in the 3rd quarter worth approximately $809,000. Finally, Great Lakes Advisors LLC bought a new position in shares of Agilon Health in the 2nd quarter worth approximately $702,000.

About Agilon Health

(Get Free Report)

Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients’ health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.

See Also

Analyst Recommendations for Agilon Health (NYSE:AGL)

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.